Literature DB >> 29727591

Alpha-linolenic acid and linoleic acid differentially regulate the skeletal muscle secretome of obese Zucker rats.

Alex Rajna1, Heather Gibling1, Ousseynou Sarr1, Sarthak Matravadia1, Graham P Holloway1, David M Mutch1.   

Abstract

Evidence shows that proteins secreted from skeletal muscle influence a broad range of metabolic signaling pathways. We previously reported that essential polyunsaturated fatty acids (PUFA) improved whole-body glucose homeostasis in obese Zucker rats; however, the mechanisms underlying these benefits remain enigmatic. While PUFA and obesity influence skeletal muscle function, their effects on the secretome are unknown. The aim of this work was to determine if improvements in whole-body glucose homeostasis in obese Zucker rats fed diets supplemented with either linoleic acid (LA) or alpha-linolenic acid (ALA) for 12 wk are related to changes in the skeletal muscle secretome. Secreted proteins were identified with a predictive bioinformatic analysis of microarray gene expression from red tibialis anterior skeletal muscle. Approximately 130 genes were differentially expressed (false discovery rate = 0.05) in obese rats compared with lean controls. The expression of 15 genes encoding secreted proteins was differentially regulated in obese controls, obese LA-supplemented, and obese ALA-supplemented rats compared with lean controls. Five secreted proteins ( Col3a1, Col15a1, Pdgfd, Lyz2, and Angptl4) were differentially regulated by LA and ALA. Most notably, ALA supplementation reduced Angptl4 gene expression compared with obese control and obese-LA supplemented rats and reduced circulating ANGPTL4 serum concentrations. ALA also influenced Angptl4 gene expression and ANGPTL4 secretion from differentiated rat L6 myotubes. Altogether, the present data indicate that obesity has a greater global impact on skeletal muscle gene expression than either essential PUFA; however, LA and ALA may exert their metabolic benefits in part by regulating the skeletal muscle secretome.

Entities:  

Keywords:  alpha-linolenic acid; linoleic acid; microarray; obesity; skeletal muscle

Mesh:

Substances:

Year:  2018        PMID: 29727591      PMCID: PMC6139631          DOI: 10.1152/physiolgenomics.00038.2018

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  62 in total

1.  Comparative proteomic analysis of the insulin-induced L6 myotube secretome.

Authors:  Jong Hyuk Yoon; Kyungmoo Yea; Jaeyoon Kim; Yoon Sup Choi; Sehoon Park; Hyeongji Lee; Chang Sup Lee; Pann-Ghill Suh; Sung Ho Ryu
Journal:  Proteomics       Date:  2009-01       Impact factor: 3.984

2.  Lipid infusion decreases the expression of nuclear encoded mitochondrial genes and increases the expression of extracellular matrix genes in human skeletal muscle.

Authors:  Dawn K Richardson; Sangeeta Kashyap; Mandeep Bajaj; Kenneth Cusi; Steven J Mandarino; Jean Finlayson; Ralph A DeFronzo; Christopher P Jenkinson; Lawrence J Mandarino
Journal:  J Biol Chem       Date:  2004-12-14       Impact factor: 5.157

Review 3.  Irisin in metabolic diseases.

Authors:  Stergios A Polyzos; Athanasios D Anastasilakis; Zoe A Efstathiadou; Polyzois Makras; Nikolaos Perakakis; Jannis Kountouras; Christos S Mantzoros
Journal:  Endocrine       Date:  2017-11-23       Impact factor: 3.633

Review 4.  Myokines in insulin resistance and type 2 diabetes.

Authors:  Kristin Eckardt; Sven W Görgens; Silja Raschke; Jürgen Eckel
Journal:  Diabetologia       Date:  2014-03-28       Impact factor: 10.122

5.  Myokine Expression in Muscle and Myotubes in Response to Exercise Stimulation.

Authors:  Jeffrey D Covington; Charmaine S Tam; Sudip Bajpeyi; Jose E Galgani; Robert C Noland; Steven R Smith; Leanne M Redman; Eric Ravussin
Journal:  Med Sci Sports Exerc       Date:  2016-03       Impact factor: 5.411

6.  Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment.

Authors:  Raghavakaimal Sreekumar; Panagiotis Halvatsiotis; Jill Coenen Schimke; K Sreekumaran Nair
Journal:  Diabetes       Date:  2002-06       Impact factor: 9.461

Review 7.  Irisin/FNDC5--An updated review.

Authors:  K Panati; Y Suneetha; V R Narala
Journal:  Eur Rev Med Pharmacol Sci       Date:  2016       Impact factor: 3.507

8.  Autocrine role of interleukin-13 on skeletal muscle glucose metabolism in type 2 diabetic patients involves microRNA let-7.

Authors:  Lake Q Jiang; Niclas Franck; Brendan Egan; Rasmus J O Sjögren; Mutsumi Katayama; Daniella Duque-Guimaraes; Peter Arner; Juleen R Zierath; Anna Krook
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-10-08       Impact factor: 4.310

9.  Fractalkine is a novel human adipochemokine associated with type 2 diabetes.

Authors:  Rachana Shah; Christine C Hinkle; Jane F Ferguson; Nehal N Mehta; Mingyao Li; Liming Qu; Yun Lu; Mary E Putt; Rexford S Ahima; Muredach P Reilly
Journal:  Diabetes       Date:  2011-05       Impact factor: 9.461

10.  Differential effects of angiopoietin-like 4 in brain and muscle on regulation of lipoprotein lipase activity.

Authors:  Sara Gry Vienberg; André Kleinridders; Ryo Suzuki; C Ronald Kahn
Journal:  Mol Metab       Date:  2014-11-13       Impact factor: 7.422

View more
  3 in total

1.  Identification and Validation of Marketing Weight-Related SNP Markers Using SLAF Sequencing in Male Yangzhou Geese.

Authors:  Sherif Melak; Qin Wang; Ye Tian; Wei Wei; Lifan Zhang; Ahmed Elbeltagy; Jie Chen
Journal:  Genes (Basel)       Date:  2021-08-03       Impact factor: 4.096

2.  α-Linolenic Acid Suppresses Proliferation and Invasion in Osteosarcoma Cells via Inhibiting Fatty Acid Synthase.

Authors:  Huijin Fan; Wenyuan Huang; Yong Guo; Xiaofeng Ma; Jianhong Yang
Journal:  Molecules       Date:  2022-04-24       Impact factor: 4.927

3.  Effect of cytokine-induced alterations in extracellular matrix composition on diabetic retinopathy-relevant endothelial cell behaviors.

Authors:  Meredith J Giblin; Cayla D Ontko; John S Penn
Journal:  Sci Rep       Date:  2022-07-28       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.